OR5H4P

Across TCGA pan-cancer cohorts, OR5H4P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated OR5H4P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher OR5H4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5H4P expression acts as an unfavorable survival marker.

DLBC, LIHC, and MESO are the cancer types where OR5H4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
LIHC	OS	Tertile	All	0.161	0.786	<.001	36	view →
MESO	OS	Tertile	II,III,IV	0.144	0.570	.033	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
SARC	DFS	Tertile	All	0.154	0.517	.031	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR5H4P–DLBC (OS)

Open the DLBC breakdown →